Axon Enterprise, Inc. (NASDAQ:AXON) Shares Sold by BIT Capital GmbH

BIT Capital GmbH decreased its holdings in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 69.0% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 4,461 shares of the biotechnology company’s stock after selling 9,923 shares during the quarter. BIT Capital GmbH’s holdings in Axon Enterprise were worth $2,651,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in AXON. Vanguard Group Inc. lifted its position in shares of Axon Enterprise by 3.4% during the 4th quarter. Vanguard Group Inc. now owns 8,446,437 shares of the biotechnology company’s stock worth $5,019,886,000 after buying an additional 275,959 shares during the last quarter. Geode Capital Management LLC lifted its position in Axon Enterprise by 2.0% in the third quarter. Geode Capital Management LLC now owns 1,782,828 shares of the biotechnology company’s stock valued at $710,103,000 after acquiring an additional 35,320 shares during the last quarter. GQG Partners LLC purchased a new position in shares of Axon Enterprise during the fourth quarter worth about $478,349,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its holdings in shares of Axon Enterprise by 1.6% during the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 561,263 shares of the biotechnology company’s stock worth $224,281,000 after purchasing an additional 9,090 shares during the last quarter. Finally, Groupama Asset Managment purchased a new position in shares of Axon Enterprise during the third quarter worth about $200,000. 79.08% of the stock is owned by institutional investors and hedge funds.

Axon Enterprise Price Performance

Shares of AXON opened at $559.06 on Thursday. The company has a current ratio of 2.96, a quick ratio of 2.63 and a debt-to-equity ratio of 0.32. The stock’s 50 day moving average is $591.51 and its two-hundred day moving average is $546.76. Axon Enterprise, Inc. has a twelve month low of $273.52 and a twelve month high of $715.99. The firm has a market capitalization of $42.84 billion, a PE ratio of 144.46, a P/E/G ratio of 5.17 and a beta of 1.12.

Analyst Upgrades and Downgrades

AXON has been the subject of a number of research analyst reports. JMP Securities reissued an “outperform” rating on shares of Axon Enterprise in a research report on Tuesday, February 4th. Barclays restated a “hold” rating on shares of Axon Enterprise in a research report on Monday, March 10th. Needham & Company LLC reiterated a “buy” rating and issued a $600.00 price target on shares of Axon Enterprise in a research report on Wednesday, February 26th. TD Cowen started coverage on shares of Axon Enterprise in a research report on Wednesday, January 8th. They set a “buy” rating and a $700.00 price objective on the stock. Finally, Craig Hallum cut shares of Axon Enterprise from a “buy” rating to a “cautious” rating in a report on Monday, March 10th. One investment analyst has rated the stock with a sell rating, two have issued a hold rating and eleven have given a buy rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $604.67.

Insider Transactions at Axon Enterprise

In other Axon Enterprise news, Director Caitlin Elizabeth Kalinowski sold 450 shares of the stock in a transaction dated Thursday, January 2nd. The shares were sold at an average price of $604.07, for a total value of $271,831.50. Following the completion of the transaction, the director now directly owns 6,929 shares of the company’s stock, valued at approximately $4,185,601.03. This trade represents a 6.10 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Jeri Williams sold 307 shares of the company’s stock in a transaction that occurred on Monday, March 17th. The stock was sold at an average price of $552.72, for a total value of $169,685.04. Following the completion of the sale, the director now owns 1,627 shares in the company, valued at approximately $899,275.44. This represents a 15.87 % decrease in their position. The disclosure for this sale can be found here. Company insiders own 6.10% of the company’s stock.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.